(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MED-LINK

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MED-LINK

ST13

US500000098098822

Class

36

Filing

98098822

Registration

7727003

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

03/19/2025

Trademark type

Word

Nice classes

36

Filing date

07/24/2023

Registration date

03/18/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/18/2025

Last transaction

03/19/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

10/20/2015

First use in commerce

01/01/2016

Drawing code

4

Owner type

16

Owner location

Jacksonville, FL

Examiner

BARREDA, AMBER

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

MED-LINK CAPITAL, LLC

Representatives

David J. Marr CLARK HILL PLC

Technical classification

Nice Classes

Class 36

Vienna Codes

No Vienna codes available.

Goods and services

Class 36

Providing uninsured and underinsured accident victims access to quality health care and providing necessary payments to pre-settlement funding health care providers on behalf of the accident victimsby assisting uninsured and underinsured accident victims with securing a source of pre-settlement funding for health care expenses in the nature of financing of health care expenses of others and payments in the nature of making necessary payments to pre-settlement funding health care providers on behalf of the accident victims

Publications

History of USPTO decisions and trademark events.

32 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/18/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

03/18/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/28/2025

PUBO

PUBLISHED FOR OPPOSITION

01/28/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/22/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/08/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/06/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/06/2025

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

01/06/2025

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

11/26/2024

GNFR

FINAL REFUSAL E-MAILED

11/26/2024

CNFR

FINAL REFUSAL WRITTEN

11/26/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/17/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/17/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/17/2024

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

10/15/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

10/15/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/15/2024

GNRT

NON-FINAL ACTION E-MAILED

07/15/2024

CNRT

NON-FINAL ACTION WRITTEN

07/15/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/14/2024

GNRT

NON-FINAL ACTION E-MAILED

05/14/2024

CNRT

NON-FINAL ACTION WRITTEN

05/14/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/08/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/08/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/08/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/02/2024

GNRT

NON-FINAL ACTION E-MAILED

04/02/2024

CNRT

NON-FINAL ACTION WRITTEN

04/02/2024

DOCK

ASSIGNED TO EXAMINER

03/26/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/22/2023

NWAP

NEW APPLICATION ENTERED

07/27/2023

Continuous trademark protection

Get notified about every new filing that threatens MED-LINK or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.